Currently, there are 282.25M common shares owned by the public and among those 208.91M shares have been available to trade.
The company’s stock has a 5-day price change of -9.22% and 84.52% over the past three months. PL shares are trading 250.28% year to date (YTD), with the 12-month market performance up to 53.47% higher. It has a 12-month low price of $1.76 and touched a high of $7.72 over the same period. PL has an average intraday trading volume of 8.31 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.05%, 27.52%, and 54.52% respectively.
Institutional ownership of Planet Labs PBC (NYSE: PL) shares accounts for 33.86% of the company’s 282.25M shares outstanding.
It has a market capitalization of $1.88B and a beta (3y monthly) value of 1.81. The earnings-per-share (ttm) stands at -$0.36. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.91% over the week and 8.35% over the month.
Analysts forecast that Planet Labs PBC (PL) will achieve an EPS of -0.05 for the current quarter, -0.05 for the next quarter and -0.11 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.06 while analysts give the company a high EPS estimate of -0.06. Comparatively, EPS for the current quarter was -0.06 a year ago. Earnings per share for the fiscal year are expected to increase by 31.72%, and 15.66% over the next financial year. EPS should grow at an annualized rate of 36.06% over the next five years, compared to 31.85% over the past 5-year period.
Looking at the support for the PL, a number of firms have released research notes about the stock. Goldman stated their Neutral rating for the stock in a research note on June 30, 2025, with the firm’s price target at $4.60. Goldman coverage for the Planet Labs PBC (PL) stock in a research note released on April 11, 2025 offered a Neutral rating with a price target of $3.50. Craig Hallum was of a view on January 30, 2025 that the stock is Buy, while Cantor Fitzgerald gave the stock Overweight rating on January 24, 2025, issuing a price target of $6.30. Needham on their part issued Buy rating on September 06, 2024.
